7,654.25

+40.25

+0.53%

52,132.00

+214.00

+0.41%

28,815.50

+281.50

+0.99%

Russell 2000 Futures

2,839.30

+18.00

+0.64%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,924.60

+25.70

+0.66%

78,298.68

+533.69

+0.69%

Crude Oil Dec 26

100.27

-3.85

-3.70%

US Private Equity

10,850.63

-82.20

-0.75%

HKSE - Delayed Quote HKD

PegBio Co., Ltd. (2565.HK)

3.775 -0.310 (-7.59%)

As of 11:59:58 AM GMT+8. Market Open.

Rani Therapeutics Announces Research and Development Collaboration with PegBio to Expand Obesity Pipeline Across Multiple Novel Candidates

GlobeNewswire 3mo ago

2565.HK
-7.59%
RANI
Lexaria Enters a Material Transfer Agreement With PegBio

ACCESS Newswire 2mo ago

LEXX

2565.HK
-7.59%
Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update

GlobeNewswire 2mo ago

RANI

2565.HK
-7.59%
Rani Therapeutics Eyes 2027 Obesity Data as Oral Biologics Platform Advances

MarketBeat 11d ago

RANI

4519.T

2565.HK
-7.59%

Mobilize your Website

View Site in Mobile | Classic

Share by: